Similarly, several studies demonstrated that activation of the IL-6-STAT3 pathway induces expansion of the stem cell-like population and acquisition of drug resistance, including hormone-independent growth in breast cancer cells [67,68,69,70,71]. The gene discussed is IL6; the disease is breast cancer.